Sequenom, Inc.
Clinical trials sponsored by Sequenom, Inc., explained in plain language.
A molecular diagnostics company known for prenatal testing, now part of Labcorp.
Trade on eToro (ad)Not investment advice. Company information is shown for context only. Clinical trials frequently fail.
-
New blood test aims to sharpen prostate cancer detection
Diagnosis Recruiting nowThis study is testing a blood test called Proclarix to see if it can better identify men with aggressive prostate cancer before they have a biopsy. About 500 men aged 40-75 with certain PSA levels will give a blood sample before their scheduled biopsy. The test results will be co…
Sponsor: Sequenom, Inc. • Aim: Diagnosis
Last updated Jul 23, 2026 00:00 UTC
-
Simple blood test may spot preeclampsia risk before symptoms appear
Diagnosis Recruiting nowThis study aims to improve early detection of preeclampsia, a dangerous pregnancy condition. Researchers will collect blood samples from over 6,500 pregnant women between 11-14 weeks of pregnancy and compare the results with pregnancy outcomes. The goal is to see how well a new b…
Sponsor: Sequenom, Inc. • Aim: Diagnosis
Last updated Jul 22, 2026 00:00 UTC